ArticleBlood advances2023

Prospective evaluation of lymphoma response to immunomodulatory therapy criteria in GATA trial from the LYSA group.

Yassine Al Tabaa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.